Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 103 entries
View as:

Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06926387 Org: User:
Start: 04/17/25 End: 04/29/25 Due: 04/29/26

YH4808 Postprandial PK/PD Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01761513 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

Phase: N/A Priority: Normal
NCT ID: NCT02496910 Org: User:
Start: 06/30/15 End: 09/30/15 Due: 09/30/16

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Phase: N/A Priority: Normal
NCT ID: NCT06625957 Org: User:
Start: 12/04/24 End: 07/18/25 Due: 07/18/26

Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06775522 Org: User:
Start: 01/11/25 End: 01/21/25 Due: 01/21/26

BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05418803 Org: User:
Start: 01/28/20 End: 02/14/20 Due: 02/14/21

Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06359626 Org: User:
Start: 06/21/24 End: 07/06/24 Due: 07/06/25

Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06613139 Org: User:
Start: 10/06/24 End: 10/24/24 Due: 10/24/25

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03067688 Org: User:
Start: 04/11/17 End: 03/27/18 Due: 03/27/19

Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03191136 Org: User:
Start: 05/10/17 End: 10/30/17 Due: 10/30/18

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06517914 Org: User:
Start: 07/29/24 End: 06/30/26 Due: 06/30/27

Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01420913 Org: User:
Start: 08/31/11 End: 08/31/11 Due: 08/31/12

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06623526 Org: User:
Start: 10/04/24 End: 11/11/24 Due: 11/11/25

Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05862194 Org: User:
Start: 06/01/15 End: 03/20/23 Due: 03/20/24

PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02783638 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17

Early Access Program of Lazertinib in Republic of Korea

Phase: N/A Priority: Normal
NCT ID: NCT04829422 Org: User:
Start: - End: - Due: -

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02968160 Org: User:
Start: 10/31/16 End: 02/28/18 Due: 02/28/19

Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04225052 Org: User:
Start: 12/19/19 End: 01/14/20 Due: 01/14/21

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Phase: N/A Priority: Normal
NCT ID: NCT01609907 Org: User:
Start: 11/30/11 End: 05/31/12 Due: 05/31/13

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05564221 Org: User:
Start: 11/01/22 End: 11/28/24 Due: 11/28/25

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01007019 Org: User:
Start: 11/30/09 End: 03/31/12 Due: 03/31/13

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01870674 Org: User:
Start: 08/31/13 End: 04/30/15 Due: 04/30/16

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03046992 Org: User:
Start: 02/15/17 End: 03/30/23 Due: 03/30/24

A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT05624853 Org: User:
Start: 05/12/20 End: 12/20/22 Due: 12/20/23

Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04056169 Org: User:
Start: 06/29/17 End: 07/23/19 Due: 07/23/20